Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 26Prostatic Neoplasms 24Brain Neoplasms 21Neoplasms 13Glioma 10Head and Neck Neoplasms 8Pancreatic Neoplasms 7Glioblastoma 6Lung Neoplasms 5Colonic Neoplasms 5Carcinoma, Hepatocellular 5Astrocytoma 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Rectal Neoplasms 4Lymphoma 4Central Nervous System Neoplasms 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Spinal Cord Neoplasms 3Sarcoma 3Liver Neoplasms 3Disease 3Retinoblastoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pathologic Complete Response 2Oligodendroglioma 2Neurofibromatosis 1 2Meningioma 2Lymphoma, Non-Hodgkin 2

Interventions

Psychiatric Rehabilitation 1Magnetic Resonance Imaging 1Caregivers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Health Status Unknown × Magnetic Resonance Imaging × Clear all
NCT03234556 2025-12-22

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

University of Southern California

Phase NA Active not recruiting
288 enrolled

Health Status Unknown

Data powered by HemOnc (CC BY 4.0) Colophon âš¡